- Trials with a EudraCT protocol (15)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (26)
15 result(s) found for: Osteoid.
Displaying page 1 of 1.
| EudraCT Number: 2005-004643-53 | Sponsor Protocol Number: 20050104 | Start Date*: 2006-03-14 |
| Sponsor Name:Amgen Inc. | ||
| Full Title: Bone Histomorphometry Assessment For Incident Dialysis Patients with Secondary Hyperparathyroidism of End Stage Renal Disease. Valoración ósea histomorfométrica en pacientes incidentes en diálisis... | ||
| Medical condition: Secondary hyperparathyroidism (HPT) in subjects with CKD receiving dialysis. Hiperparatiroidismo (HPT) secundario en sujetos con IRC tratados con Diálisis. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Completed) HU (Completed) CZ (Completed) PT (Completed) IT (Completed) BE (Completed) GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-001698-41 | Sponsor Protocol Number: P140909 | Start Date*: 2016-02-12 | |||||||||||
| Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
| Full Title: Non-inferiority trial of three cycles of zoledronic acid versus percutaneous thermal ablation in osteoid osteoma | |||||||||||||
| Medical condition: | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2016-005244-42 | Sponsor Protocol Number: 20159990 | Start Date*: 2018-06-04 | |||||||||||||||||||||||||||||||
| Sponsor Name:Leiden University Medical Center | |||||||||||||||||||||||||||||||||
| Full Title: An Open-label, Multi-center, Phase 2 Study of Denosumab in Subjects with Giant Cell Rich Tumors of Bone. | |||||||||||||||||||||||||||||||||
| Medical condition: Aneurysmal bone cysts, giant cell granuloma, other giant cell rich lesions (primary bone, non-malignant) | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
| Trial protocol: NL (Completed) FR (Prematurely Ended) | |||||||||||||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||||||||||||
| EudraCT Number: 2010-018543-34 | Sponsor Protocol Number: 12153599 | Start Date*: 2010-06-11 | |||||||||||
| Sponsor Name:Orthopaedic Syrgery Unit Northern Jytland | |||||||||||||
| Full Title: NSAIDs INFLUENCE ON HEAL OF COLLES FRACTURE | |||||||||||||
| Medical condition: Ivestigations hypotheses: 1. NSAIDs provide a significant postoperative pain relief that can make mobilization / rehabilitation faster and easier oedema prophylaxis. 2. NSAIDs do not affect bone he... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2015-001775-41 | Sponsor Protocol Number: UX023-CL304 | Start Date*: 2015-12-16 | |||||||||||
| Sponsor Name:Ultragenyx Pharmaceutical Inc. | |||||||||||||
| Full Title: An Open-Label, Single-Arm, Phase 3 Study to Evaluate the Effects of KRN23 on Osteomalacia in Adults with X-linked Hypophosphatemia (XLH) | |||||||||||||
| Medical condition: XLH is a disorder of hypophosphatemia, renal phosphate wasting, and the most common inheritable form of rickets. In XLH patients, excess circulating fibroblast growth factor (FGF23) impair phospha... | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) FR (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2005-000515-95 | Sponsor Protocol Number: B3D-EW-GHCX | Start Date*: 2005-06-16 |
| Sponsor Name:Eli Lilly and Company Limited | ||
| Full Title: Differential Effects of Teriparatide and Strontium Ranelate on Bone Remodeling and Formation in Postmenopausal Women with Osteoporosis: A Histomorphometric Study | ||
| Medical condition: Osteoporosis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: CZ (Completed) ES (Completed) DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-000615-84 | Sponsor Protocol Number: OCTO_039 | Start Date*: 2014-11-08 | |||||||||||
| Sponsor Name:University of Oxford | |||||||||||||
| Full Title: A Mechanistic Study Of Mifamurtide (MTP-PE) In Patients With Metastatic And/Or Recurrent Osteosarcoma | |||||||||||||
| Medical condition: Relapsed or metastatic osteosarcoma | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) NL (Completed) DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2015-004762-28 | Sponsor Protocol Number: OsteoREC2015 | Start Date*: 2016-02-25 | |||||||||||
| Sponsor Name:ITALIAN SARCOMA GROUP | |||||||||||||
| Full Title: Multicentric prospective, randomized, clinical trial for the treatment of patient with relapsed Osteosarcoma (OS) | |||||||||||||
| Medical condition: high grade relapsed osteosarcoma | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2006-003377-27 | Sponsor Protocol Number: Sarcome 09/0603 | Start Date*: 2007-02-20 | |||||||||||
| Sponsor Name:Fédération Nationale des Centres de Lutte Contre le Cancer | |||||||||||||
| Full Title: Etude Intergroupe (SFCE/GSF/GETO) OS2006 Zolédronate-Ostéosarcome Protocole de traitement des ostéosarcomes de l’enfant, de l’adolescent et de l’adulte comportant : - un essai randomisé - et des é... | |||||||||||||
| Medical condition: Les biphosphonates sont des analogues synthétiques des pyrophosphates endogènes dont la fonction principale est d’inhiber la résorption osseuse. Leur utilisation s’est imposée depuis une dizaine d’... | |||||||||||||
|
|||||||||||||
| Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2011-005554-62 | Sponsor Protocol Number: ASSG03 | Start Date*: 2012-04-16 | |||||||||||||||||||||
| Sponsor Name:Australian Sarcoma Group (ASSG) | |||||||||||||||||||||||
| Full Title: Pharmacokinetics and Pharmacodynamics of Doxorubicin in Children, Adolescents and young adults with Newly Diagnosed Osteosarcoma, Ewing Family of Tumours and Hodgkin Lymphoma A Multi-Institutional ... | |||||||||||||||||||||||
| Medical condition: Ewing family of tumours Osteosarcoma Hodgkin lymphoma | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2016-001676-29 | Sponsor Protocol Number: MK3475_PROMO | Start Date*: 2016-10-27 |
| Sponsor Name:Oslo University Hospital (OUS) | ||
| Full Title: PROMO: A phase II study of Pembrolizumab in patients with Relapsed Or Metastatic Osteosarcoma not eligible for curative surgery | ||
| Medical condition: Osteosarcoma, not eligible for curative surgery | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NO (Completed) IT (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-003595-12 | Sponsor Protocol Number: ADVL1322-VEG116731 | Start Date*: 2013-09-04 |
| Sponsor Name:GlaxoSmithKline | ||
| Full Title: A Phase II Study of Pazopanib in Children, Adolescents and Young Adults with Refractory Solid Tumors. | ||
| Medical condition: relapsed solid tumours in children, adolescents and young adults. | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA CZ (Completed) SK (Completed) ES (Completed) HU (Completed) FR (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-000383-15 | Sponsor Protocol Number: BAY80-6946/19176 | Start Date*: 2023-06-05 | ||||||||||||||||||||||||||||||||||||
| Sponsor Name:Bayer AG | ||||||||||||||||||||||||||||||||||||||
| Full Title: A non-randomized, open-label, multi-center, Phase I/II study of PI3K inhibitor copanlisib in pediatric patients with relapsed/refractory solid tumors or lymphoma | ||||||||||||||||||||||||||||||||||||||
| Medical condition: Relapsed or refractory solid tumors or lymphoma in children Neuroblastoma Osteosarcoma Rhabdomyosarcoma Ewing sarcoma | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
| Trial protocol: Outside EU/EEA | ||||||||||||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2019-002931-27 | Sponsor Protocol Number: I3Y-MC-JPCS | Start Date*: 2020-10-03 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sponsor Name:Eli Lilly and Company | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Full Title: A Phase 1b/2 Study of Abemaciclib in Combination with Irinotecan and Temozolomide (Part A) and Abemaciclib in Combination with Temozolomide (Part B) in Pediatric and Young Adult Patients with Rela... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Medical condition: Pediatric and Young Adult Patients Relapsed/Refractory Solid Tumors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial protocol: BE (Completed) DE (Trial now transitioned) IT (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2014-004697-41 | Sponsor Protocol Number: GO29664 | Start Date*: 2015-08-19 | ||||||||||||||||||||||||||||||||||||||||||||||
| Sponsor Name:F. Hoffmann-La Roche Ltd | ||||||||||||||||||||||||||||||||||||||||||||||||
| Full Title: AN EARLY-PHASE, MULTICENTER, OPEN-LABEL STUDY OF THE SAFETY AND PHARMACOKINETICS OF ANTI−PD-L1 ANTIBODY (MPDL3280A) IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH PREVIOUSLY TREATED SOLID TUMORS | ||||||||||||||||||||||||||||||||||||||||||||||||
| Medical condition: Pediatric solid tumors for which prior treatment has proven to be ineffective (i.e., relapsed or refractory) or intolerable | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
| Trial protocol: DK (Completed) DE (Completed) IE (Completed) ES (Completed) FR (Completed) AT (Completed) NL (Completed) IT (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||||||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
